XSULIN 30/70 ERIS 1 Disposable Pen 1's

XSULIN 30/70 ERIS 1 DISPOSABLE PEN contains Biphasic Isophane Insulin which belongs to the group of medicines called Antidiabetic agents. It improves glycemic control in patients with diabetes mellitus (both type I and type II). It helps your body to make utilize of the circulating blood glucose by transporting the circulating glucose from the blood into the muscles and fat tissues.

Biphasic Isophane Insulin is a pre-mixed combination of Regular (soluble) insulin and Isophane (NPH) insulin. It is a fast-acting medicine where it begins to lower blood sugar levels within 30 minutes. Therefore, inject the medicine 30 minutes before meal and make sure to have your meals within the next 30 minutes.

Talk to your doctor before starting therapy with XSULIN 30/70 ERIS 1 DISPOSABLE PEN if you have any liver, kidney or heart problems. You must also inform your doctor if you have any hormonal problems, made sudden changes to your diet or perform intense exercise as a precaution. Do not use this medicine if you have hypoglycemia (low blood sugar levels). Consult your doctor before using this medicine if you are pregnant or breastfeeding.

The most common side effects of receiving XSULIN 30/70 ERIS 1 DISPOSABLE PEN are low blood sugar levels, pain, redness, itching, swelling or thickening at the injection site, lump formation under the skin and swelling of body parts. Consult your doctor if any of these side effect troubles you.

USES OF XSULIN 30/70 ERIS 1 DISPOSABLE PEN

• Improves glycemic control in patients with diabetes mellitus (both type I and type II)

HOW XSULIN 30/70 ERIS 1 DISPOSABLE PEN WORKS

XSULIN 30/70 ERIS 1 DISPOSABLE PEN helps your body to make utilize of the circulating blood glucose. It helps in the transport of glucose from the blood into the muscles and fat tissues. It also stops the production of glucose by the liver. As a result, it controls blood sugar levels and improve glycemic control in patients with diabetes mellitus.

DIRECTIONS FOR USE

Use XSULIN 30/70 ERIS 1 DISPOSABLE PEN under careful medical supervision. Inject XSULIN 30/70 ERIS 1 DISPOSABLE PEN into your thighs, buttocks, upper arm, or abdomen (i.e., subcutaneously). Do not administer this medicine into the vein or muscle directly. It should be administered at least 10 minutes before meals. Eat a meal or snack containing carbohydrates within 20 minutes of the injection to avoid low blood sugar.

Before administration, roll the vial/cartridge between your hands until the liquid becomes uniformly white and cloudy. While injecting, keep the needle under the skin for at least 6 seconds to make sure that the entire dose is injected.

Prior to the administration, visualize the cartridge/vial for any visible particulate matter and discoloration. Discard the needle and syringe after use and do not share your needles with others to avoid the risk of transmission of infections.

Avoid repeatedly injecting the medicine at the same site to manage skin damage. Instead, rotate the injection site. Make sure to consult your doctor before changing the injection site as a precaution.

XSULIN 30/70 ERIS 1 DISPOSABLE PEN should not be mixed with any other insulins before use. Do not stop therapy with XSULIN 30/70 ERIS 1 DISPOSABLE PEN without consulting your doctor. Your doctor will decide correct dose and frequency of administration depending upon your age, body weight and health condition.

SIDE EFFECTS OF XSULIN 30/70 ERIS 1 DISPOSABLE PEN

COMMON

• Injection site reactions (such as pain, redness, itching or swelling)
• Lipodystrophy (shrinkage of fat tissues beneath the skin)
• Lumps under the skin
• Weight gain, swelling of body parts
• Hypoglycemia (Low blood sugar levels)

UNCOMMON

• diabetic retinopathy (eye diseases due to diabetes)
• swelling around the ankles and other joints
• painful neuropathy (pain caused by nerve damage)

RARE

• problem in vision

Consult your doctor immediately if you experience any of the following side effects:

• allergic reaction (generalized skin rash with itching, sweating, and swelling of layers under the skin, difficulties in breathing, palpitation, vomiting, stomach upset, reduction in blood pressure and fainting /loss of consciousness)
• signs of severe hypoglycemia (such as cold sweats, cool pale skin, headache, rapid heartbeat, nausea, increased hunger, temporary vision changes, drowsiness, tiredness and weakness, nervousness or tremor, anxiety, confusion and difficulty in concentrating)